Page 179 - Genentech News Today

‒ Vabysmo data suggest rapid and robust drying of retinal fluid in patients with wet age-related macular degeneration and diabetic macular edema –‒ Real-world studies of Vabysmo demonstrate ability to extend treatment intervals in the first four months while maintaining visual acuity –‒ Clinical data on an investiga...

Despite a high-profile clinical disappointment, the TIGIT immune checkpoint remains an important target for anticancer therapy, with research programs testing novel agents moving forward in non–small cell lung cancer and a range of other tumor types.

Ariel Skelley | DigitalVision | Getty Images

This past week in healthcare investigations

Roche introduces navify® Algorithm Suite, a digital library of medical algorithms that enhances clinical decision-making to optimise patient care ·        At the global HIMSS1 Conference, Roche showcases navify Algorithm Suite, a single platform offering clinicians...

Starting this May, children with SMA in New Zealand will be able to access Evrysdi through the country's publicly funded healthcare system. 

Sparing lymph nodes until after immunotherapy treatment may result in improved antitumor immune response among patients with cancer, according to a study published in Cell. “This study helps clarify how immunotherapies work and where the reservoir of cells is that is responding to the therapies, so we can think about developing better immunotherapies that harness those cells in the lymph

Keys To Surviving The High-Tech Startup Jungle

At the global HIMSS1 Conference, Roche showcases navify Algorithm Suite, a single platform offering clinicians access to medical algorithms generating insights...

December - International News Snippets.       Uk - Marshall Farms Company Update Marshall Bioscience farms - the US company proposing to build an intensive breeding unit in E. Yorkshire for 2,000 beagles for laboratory experiments - have a similar breeding unit operating in Montichiari Italy called Green Hill. Green Hill has recently been…